Ambrx Biopharma
(NYSE:AMAM)
2.85
0.01[0.35%]
At close: Jun 24
4.57
1.7200[60.35%]
After Hours: 4:02PM EDT
Day High/Low2.8 - 2.94
52 Week High/Low2.52 - 22.87
Open / Close2.94 / 2.87
Float / Outstanding- / 38.6M
Vol / Avg.3.4K / 7.7K
Mkt Cap110M
P/E-
50d Avg. Price3.85
Div / Yield-
Payout Ratio-
EPS-
Total Float36.6M

Ambrx Biopharma (NYSE:AMAM), Quotes and News Summary

Ambrx Biopharma (NYSE: AMAM)

Day High/Low2.8 - 2.94
52 Week High/Low2.52 - 22.87
Open / Close2.94 / 2.87
Float / Outstanding- / 38.6M
Vol / Avg.3.4K / 7.7K
Mkt Cap110M
P/E-
50d Avg. Price3.85
Div / Yield-
Payout Ratio-
EPS-
Total Float36.6M
load more
Sector: Health Care.Industry: Biotechnology
Ambrx Biopharma Inc is a clinical-stage biologics company focused on discovering and developing a novel class of engineered precision biologics (EPBs) using its proprietary expanded genetic code technology platform that allows incorporating synthetic amino acids (SAAs) into proteins within living cells. Its product pipeline includes ARX788, ARX517, ARX305 among others.

Earnings

see more
FY 2021Est.ActualSurprise
EPS-0.480
REV7.455M
H1 2021Est.ActualSurprise
EPS-1.630
REV5.132M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Ambrx Biopharma Questions & Answers

Q
How do I buy Ambrx Biopharma (AMAM) stock?
A

You can purchase shares of Ambrx Biopharma (NYSE: AMAM) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Ambrx Biopharma's (AMAM) competitors?
Q
What is the target price for Ambrx Biopharma (AMAM) stock?
A

The latest price target for Ambrx Biopharma (NYSE: AMAM) was reported by Goldman Sachs on Tuesday, May 24, 2022. The analyst firm set a price target for 4.00 expecting AMAM to rise to within 12 months (a possible 40.35% upside). 6 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Ambrx Biopharma (AMAM)?
A

The stock price for Ambrx Biopharma (NYSE: AMAM) is $2.85 last updated June 24, 2022, 3:43 PM UTC.

Q
Does Ambrx Biopharma (AMAM) pay a dividend?
A

There are no upcoming dividends for Ambrx Biopharma.

Q
When is Ambrx Biopharma (NYSE:AMAM) reporting earnings?
A

Ambrx Biopharma’s FY earnings are confirmed for Tuesday, April 26, 2022.

Q
Is Ambrx Biopharma (AMAM) going to split?
A

There is no upcoming split for Ambrx Biopharma.

Q
What sector and industry does Ambrx Biopharma (AMAM) operate in?
A

Ambrx Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.